Use of Direct Oral Anticoagulants in Patients With Antiphospholipid Syndrome: A Systematic Review and Comparison of the International Guidelines

Use of Direct Oral Anticoagulants in Patients With Antiphospholipid Syndrome: A Systematic Review and Comparison of the International Guidelines

Antiphospholipid antibody syndrome (APS) requires long-term anticoagulation to prevent recurrent thrombosis. Direct oral anticoagulants (DOACs) have been increasingly used in APS patients, but contradictory guidelines recommendations on their use do exist. We performed a systematic review of literat...

Full description

Bibliographic Details
Main Authors: Daniele Pastori, Danilo Menichelli, Vittoria Cammisotto, Pasquale Pignatelli
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
vitamin K antagonists
direct oral anticoagulants
antiphospholipid antibody syndrome
guideline
anticoagulants
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2021.715878/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2021.715878/full

Similar Items